13F reference period
Q3 2026
Security Snapshot
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) Institutional Ownership
CUSIP: 14161Y200
13F Institutional Holders and Ownership History from Q4 2019 to Q3 2026
Institutions Reporting
32
Shares (Excl. Options)
25.4M
Full value: 25,396,776 · shares · 30 Sep 2026Price
$1.66
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Common Shares
- Symbol
- CRDL on Nasdaq
- All holders as of 30 Sep 2026
- Q3 2026
- Total 13F shares
- 25,396,776
- Total 13F value
- $42,160,302
- Portfolio coverage rank
- 0%
- Share change
- +2,404,804
- Value change
- +$4,488,689
- Number of holders
- 32
- Shares outstanding
- 120,425,491
- SEC-reported price per share
- $1.18
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- CRDL - Cardiol Therapeutics Inc. - Class A Common Shares is tracked under CUSIP 14161Y200.
- 32 institutions reported positions in Q3 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 52 to 32 between Q2 2026 and Q3 2026.
- SEC-reported value moved from to
$31.28M
Full value: $31,283,207 · USD · 30 Jun 2026.$42.16M
Full value: $42,160,302 · USD · 30 Sep 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 32 institutions filings for Q3 2026.
Security key
14161Y200
13F reference period
Q3 2026
13F holders
32
13D/G owners
2
CIK / CUSIP context first
Open Q3 2026 holders
CRDL full holder history
Cardiol Therapeutics Inc. SEC filings
Cardiol Therapeutics Inc. company facts
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 14161Y200:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
CRDL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 18% | -1.7% | $21,523,200 | +$248,705 | 21,310,099 | +1.2% | MMCAP International Inc. SPC | 30 Jun 2026 |
| Tejara Capital Ltd | 5.3% | +2% | $12,382,149 | +$2,429,712 | 6,382,551 | +24% | Tejara Capital Ltd | 02 Sep 2026 |
As of 30 Sep 2026,
32
institutional investors reported holding
shares of
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL).
This represents
21%
of the company’s total
outstanding shares.
25.4M
Full value: 25,396,776 · shares · 30 Sep 2026120.43M
Full value: 120,425,491 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
21%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 13% | 15,598,560 | 0% | 1.7% | $25,893,610 |
| Tejara Capital Ltd | 6.2% | 7,420,429 | +45% | 6% | $12,317,912 |
| MORGAN STANLEY | 0.84% | 1,010,687 | +185% | 0% | $1,677,740 |
| INTEGRITY ALLIANCE, LLC. | 0.26% | 310,896 | -20% | 0.02% | $516,087 |
| PVG ASSET MANAGEMENT CORP | 0.09% | 111,865 | +4.4% | 0.13% | $185,696 |
| STATE STREET CORP | 0.08% | 100,000 | 0% | $166,000 | |
| Birchview Capital, LP | 0.08% | 100,000 | 0.1% | $166,000 | |
| 1832 Asset Management L.P. | 0.08% | 100,000 | 0% | 0% | $166,000 |
| MGO ONE SEVEN LLC | 0.08% | 100,000 | 0% | 0% | $166,000 |
| AIGH Capital Management LLC | 0.08% | 100,000 | 0.02% | $166,000 | |
| Summit Financial, LLC | 0.08% | 93,575 | -5.6% | 0% | $155,335 |
| Marble Harbor Investment Counsel, LLC | 0.03% | 39,900 | 0% | 0.01% | $66,234 |
| Boyer Financial Services, Inc. | 0.03% | 34,100 | 0% | 0.05% | $56,606 |
| CIBC WORLD MARKET INC. | 0.03% | 33,295 | 0% | $55,460 | |
| Quadrature Capital Ltd | 0.03% | 31,994 | +4.7% | 0% | $53,116 |
| Concurrent Investment Advisors, LLC | 0.02% | 25,387 | 0% | 0% | $42,142 |
| Boomfish Wealth Group, LLC | 0.02% | 22,841 | +58% | 0.02% | $37,916 |
| RAYMOND JAMES FINANCIAL INC | 0.02% | 21,379 | 0% | $35,489 | |
| Aurora Private Wealth, Inc. | 0.02% | 21,000 | 0% | 0.02% | $35,000 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.02% | 18,467 | -56% | 0% | $30,655 |
| LPL Financial LLC | 0.01% | 17,650 | +40% | 0% | $29,299 |
| Independent Advisor Alliance | 0.01% | 15,645 | +56% | 0% | $25,971 |
| MONECO ADVISORS, LLC | 0.01% | 15,000 | 0% | 0% | $24,900 |
| Creative Planning | 0.01% | 12,308 | -30% | 0% | $20,431 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.01% | 11,495 | 0% | 0% | $19,080 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
27
Headline period
Q3 2026
Rows shown
1-25 of 27
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 25,396,776 | $42,160,302 | +$4,488,689 | $1.66 | 32 |
| 2026 Q2 | 29,513,969 | $31,283,207 | +$1,701,230 | $1.06 | 52 |
| 2026 Q1 | 27,859,784 | $37,577,318 | +$25,774,247 | $1.35 | 46 |
| 2025 Q4 | 9,101,664 | $8,688,287 | +$1,769,497 | $0.95 | 41 |
| 2025 Q3 | 7,282,619 | $7,797,682 | +$687,878 | $1.07 | 47 |
| 2025 Q2 | 6,465,422 | $8,796,830 | -$1,669,184 | $1.36 | 38 |
| 2025 Q1 | 7,719,601 | $7,435,013 | +$182,305 | $0.97 | 38 |
| 2024 Q4 | 7,493,301 | $9,599,808 | +$3,011,551 | $1.28 | 43 |
| 2024 Q3 | 4,972,709 | $9,852,940 | -$780,395 | $1.98 | 41 |
| 2024 Q2 | 5,391,195 | $10,832,854 | -$2,207,214 | $2.02 | 41 |
| 2024 Q1 | 6,466,600 | $11,532,275 | +$17,221 | $1.81 | 32 |
| 2023 Q4 | 6,828,316 | $5,921,144 | +$428,207 | $0.84 | 29 |
| 2023 Q3 | 6,315,038 | $5,705,102 | -$336,357 | $0.90 | 31 |
| 2023 Q2 | 6,680,430 | $5,957,333 | -$451,394 | $0.89 | 30 |
| 2023 Q1 | 7,243,437 | $3,537,761 | +$172,240 | $0.49 | 31 |
| 2022 Q4 | 5,656,495 | $2,897,996 | +$187,861 | $0.51 | 28 |
| 2022 Q3 | 4,751,290 | $4,889,869 | -$537,769 | $1.03 | 22 |
| 2022 Q2 | 5,288,416 | $6,964,240 | -$155,145 | $1.32 | 24 |
| 2022 Q1 | 5,387,006 | $8,272,481 | -$917,566 | $1.54 | 26 |
| 2021 Q4 | 5,796,080 | $10,710,997 | +$7,739,960 | $1.85 | 27 |
| 2021 Q3 | 1,605,991 | $6,624,465 | +$6,624,465 | $4.13 | 19 |
| 2021 Q1 | 0 | $0 | -$970,000 | $1.18 | 0 |
| 2020 Q4 | 348,769 | $970,000 | +$171,498 | $2.78 | 1 |
| 2020 Q3 | 287,106 | $876,000 | +$133,036 | $3.05 | 1 |
| 2020 Q2 | 243,504 | $577,000 | +$78,276 | $2.37 | 1 |